Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 421
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06921044 | A Study of R-mini-MCOP in the Treatment of Elderly, Previously Untreated DLBCL | ||
| NCT06087068 | Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma | ||
| NCT06842472 | PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer | ||
| NCT06483672 | Furmonertinib Combined With Anlotinib in Lung Adenocarcinoma Patients With EGFR Mutations and Brain Metastases | ||
| NCT06202001 | Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients | ||
| NCT06544668 | A Study for Dynamic Prediction Model of Breast Cancer Bone Metastases | ||
| NCT05443672 | Multi-center Study of Deep Learning AI in Breast Mass | ||
| NCT06405269 | Effect of (neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients | ||
| NCT06908668 | Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer | ||
| NCT06577792 | Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY) | ||
| NCT06824792 | Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System | ||
| NCT00700440 | Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy | ||
| NCT04850040 | A Neoadjuvant Hepatocellular Carcinoma Study of Camrelizumab in Combination With Apatinib and Oxaliplatin | ||
| NCT06048146 | A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis | ||
| NCT07026669 | A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer | ||
| NCT06858969 | Chidamide in Combination With PD-1 Inhibitor, Bevacizumab, and XELOX for Metastatic Colorectal Cancer | ||
| NCT06592092 | Clinical Study of QH104 Cell Injection for the Treatment of Meningeal Metastases of B7H3+ Solid Tumors | ||
| NCT06413992 | Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer | ||
| NCT04822792 | Pan-canceR Early-Stage deteCtion by lIquid Biopsy tEchNique projecT | ||
| NCT03298204 | Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01 | ||
| NCT06435767 | Quantitative Nodal Burden as a Determinant Identifying Ampullary Adenocarcinoma Patients Benefiting From Adjuvant Chemotherapy | ||
| NCT06178601 | A Study of RC48-ADC Combined With Cadonilimab（AK104）in the Treatment of HER2-expression Locally Advanced or Metastatic Urothelial Carcinoma | ||
| NCT04972201 | A Proof of Concept Study of Pan-cancer Early Detection by Liquid Biopsy | ||
| NCT06417892 | Fruquintinib and Albumin-paclitaxel Combined With or Without PD-1 Antibody in 2nd-line Treatment of G/GEJ Adenocarcinoma | ||
| NCT06051760 | NV-001 in the Treatment of Advanced Solid Tumors | ||
| NCT04339660 | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia | ||
| NCT06492629 | Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma | ||
| NCT06490380 | HRD Status Reference Standard Based on WGS | ||
| NCT06082180 | A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer | ||
| NCT07037680 | Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT | ||
| NCT03351062 | Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer | ||
| NCT01733589 | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC | ||
| NCT03751592 | Phase Ib/IIa Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Advanced Lung Cancer | ||
| NCT05749289 | Application of Al18F-octreotide PET/CT in Neuroendocrine Tumor | ||
| NCT05524389 | Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions | ||
| NCT04099589 | Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma | ||
| NCT03405272 | Safety and Efficacy of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Wild-type RAS and BRAF mCRC | ||
| NCT03713372 | Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma | ||
| NCT07046780 | A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors | ||
| NCT05542680 | Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal Cancer | ||
| NCT04709380 | Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT | ||
| NCT03955367 | Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer | ||
| NCT05431504 | The Efficacy and Safety of Dalpiciclib Plus Endocrine Therapy in HR-positive / HER2-negative Advanced Breast Cancer Patients With Visceral Crisis | ||
| NCT06342167 | Efficacy and Safety of Concurrent PD-1 Inhibitor and Radiotherapy With Immunonutrition for Esophageal Squamous Cell Carcinoma | ||
| NCT07043894 | Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients | ||
| NCT03058094 | A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI | ||
| NCT05983094 | Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer | ||
| NCT05523960 | Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery | ||
| NCT06691594 | Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy | ||
| NCT03844360 | Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease |
